Physician profile
Ashok Krishnamurthy
NPI 1083623565
$4,321.65
in general payments reported to CMS, 2019-2025
29 companies · $620 in 2025
The $620 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $485 · 2020: $532 · 2021: $245 · 2022: $669 · 2023: $442 · 2024: $1,329 · 2025: $620.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,391.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,390.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,167.12 | 2020-2025 | Mitraclip, Navitor, Triclip |
| Boston Scientific Corporation | $400.14 | 2019-2025 | Eluvia, Accolade Sr, Resonate El Icd Vr |
| Abiomed | $326.86 | 2023-2025 | Impella |
| Inari Medical, INC. | $313.81 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Amgen INC. | $253.19 | 2019-2025 | Repatha |
| Biotronik INC. | $232.75 | 2020-2022 | |
| Cvrx, INC. | $228.46 | 2022-2025 | Barostim Neo System |
| Novartis Pharmaceuticals Corporation | $167.91 | 2022-2023 | |
| Pfizer INC. | $147.66 | 2020-2022 | |
| Edwards Lifesciences Corporation | $143.97 | 2023 | Konect Resilia |
| Stryker Corporation | $126.63 | 2025 | Artix Mt, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Astrazeneca Pharmaceuticals Lp | $122.58 | 2020-2023 | Farxiga |
| Philips North America LLC | $110.89 | 2022-2025 | (Ck7) Extended Holter, Event |
| Terumo Medical Corporation | $93.60 | 2019 | |
| Janssen Pharmaceuticals, INC | $90.60 | 2019-2024 | Xarelto |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $66.32 | 2024-2025 | Cardiva Vascade 6/7f Vcs, Optowire, Cardiva Vascade Mvp Vvcs 6-12f |
| Kestra Medical Technology Services, INC. | $60.86 | 2022 | |
| Medtronic Vascular, INC. | $46.86 | 2019 | |
| Medtronic, INC. | $38.33 | 2023 | Micra |
| Kiniksa Pharmaceuticals International, Plc | $30.38 | 2024 | Arcalyst |
| Preventice Services, LLC | $27.90 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $26.22 | 2025 | Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.33 | 2025 | Lifevest |
| Alnylam Pharmaceuticals INC. | $22.49 | 2025 | Onpattro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.82 | 2022 | |
| Heartflow, INC. | $17.61 | 2025 | |
| Cook Medical LLC | $14.36 | 2023 | Zilver Ptx |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashok Krishnamurthy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.